Belgium· BE-AMP-SAM463635-00

Salmeterol/Fluticason Cipla 25 µg/dose - 125 µg/dose

A salmeterol and fluticasone product containing salmeterol xinafoate, registered in Belgium by Cipla Europe. The same ATC class is registered in 14 of our 19 countries.

ATC R03AK06

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about salmeterol xinafoateAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Salmeterol and fluticasone is registered in 14 of 19 countries.

Countries holding a registration under ATC R03AK06 (salmeterol and fluticasone), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
9 of them publish a price we can compare per daily dose

Search salmeterol and fluticasone products by name

Salmeterol and fluticasone · ATC R03AK06

14 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Salmeterol Xinafoate
Manufacturer: Cipla Europe
Country: Belgium (BE)
ATC code: R03AK06
ATC class: Salmeterol and fluticasone
Defined daily dose: 0.1 mg, Inhal
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 2

be_apb
3238565
be_apb
7712441

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

718 interactions on record for salmeterol and fluticasone.

Graded by severity as the source publishes them — 49 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check salmeterol and fluticasone against other medicines How interaction checks work

Salmeterol and fluticasone · interactions on record

718 records

49 severe
397 moderate
24 minor
248 info

Most severe, free to view

LonafarnibA16AX20severe
ConivaptanC03XA02severe
PindololC07AA03severe
PropranololC07AA05severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Salmeterol and fluticasone in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All salmeterol and fluticasone products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

Austria · Serevent Diskus, Serevent Evohaler
Cyprus · Serevent Diskus, Serevent Evohaler
Czechia · Serevent Diskus
Germany · Serevent Diskus, Serevent Dosier-Aerosol
Denmark · Salmeterol Orifarm, Serevent
Estonia · Serevent Diskus
Spain · Beglan, Beglan Accuhaler
Finland · Salmeterol Orifarm, Serevent Diskus
France · Serevent, Serevent Diskus
United Kingdom (Northern Ireland) · Neovent Cfc- Free Inhaler, Serevent Accuhaler
Greece · Salment, Serehal
Croatia · Serevent Diskus, Serevent Inhaler
Hungary · Serevent Diskus, Serevent Evohaler
Ireland · Serevent Diskus, Serevent Evohaler
Iceland · Serevent, Serevent Diskus
Italy · Salmetedur, Serevent
Lithuania · Serevent, Serevent Diskus
Luxembourg · Serevent Diskus, Serevent Evohaler
Latvia · Serevent
Malta · Serevent Evohaler
Netherlands · Serevent Diskus, Serevent Inhalator Cfk-Vrij
Norway · Salmeterol Orifarm, Serevent
Poland · Asmetic, Pulmoterol
Portugal · Dilamax Diskus, Dilamax Inalador
Sweden · Salmeterol Orifarm, Serevent Diskus
Slovenia · Serevent
Slovakia · Serevent Diskus, Serevent Inhaler N

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/dda86227-459a-43cd-b522-c59484fcb73b
GET /v1/drugs/dda86227-459a-43cd-b522-c59484fcb73b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Pressurised inhalation, suspension",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Salmeterol/Fluticason Cipla 25 µg/dose - 125 µg/dose",
  "name_fr": "Salmeterol/Fluticason Cipla 25 µg/dose - 125 µg/dose",
  "name_nl": "Salmeterol/Fluticason Cipla 25 µg/dose - 125 µg/dose",
  "amp_code": "SAM463635-00",
  "strengths": [
    "36.3200",
    "25.0000",
    "125.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Salmeterol Xinafoate",
    "Salmeterol",
    "Fluticasone Propionate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Salmeterol and Fluticasone",
  "authorisation_numbers": [
    "BE463635"
  ]
}

API reference MCP server Plans

See everything about salmeterol and fluticasone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console